← Evidence map

ReviewCancers2025

Possibilities of Overcoming Resistance to Osimertinib in NSCLC Patients with Mutations in the

Marcin Nicoś et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 40002158